UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-QSB
x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2003
OR
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number 0001087216
Alliance HealthCard, Inc.
(Exact name of registrant as specified in its charter)
GEORGIA | 58-2445301 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
3500 Parkway Lane, Suite 720, Norcross, GA 30092
(Address of principal executive offices and zip code)
Registrants telephone number, including area code: (770) 734-9255
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate the number of shares outstanding of the Registrants common stock as of the latest practicable date.
Class |
Outstanding at January 31, 2004 | |
Common Stock, $.001 par value |
4,494,263 |
PAGE | ||||
PART I. |
FINANCIAL INFORMATION | |||
Item 1. |
Financial Statements | |||
Balance Sheets as of December 31, 2003 and September 30, 2003 | 3 | |||
Statements of Operations for the Three Months Ended December 31, 2003 and 2002 | 4 | |||
Statements of Cash Flows for the Three Months Ended December 31, 2003 and 2002 | 5 | |||
Notes to Financial Statements | 6 | |||
Item 2. |
Managements Discussion and Analysis of Financial Condition and Results of Operations | 7 | ||
Item 3. |
Quantitative and Qualitative Disclosure of Market Risk | 8 | ||
PART II. |
OTHER INFORMATION | |||
Item 6. |
Exhibits and Reports on Form 8-K | 8 | ||
9 |
2
Item 1. | Financial Statements |
Alliance HealthCard, Inc.
Balance Sheets
December 31, 2003 |
September 30, 2003 |
|||||||
Assets |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 98,510 | $ | 249,831 | ||||
Accounts receivable, net |
1,551,649 | 1,402,817 | ||||||
Prepaid expenses and other current assets |
33,472 | 154,772 | ||||||
Total current assets |
1,683,631 | 1,807,420 | ||||||
Furniture and equipment, net |
65,349 | 75,709 | ||||||
Other assets |
10,249 | 10,249 | ||||||
Total assets |
$ | 1,759,229 | $ | 1,893,378 | ||||
Liabilities and stockholders equity |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 1,583,715 | $ | 1,680,877 | ||||
Accrued salaries and benefits |
214,570 | 248,239 | ||||||
Deferred revenue |
1,356,749 | 1,837,532 | ||||||
Other accrued liabilities |
196,456 | 149,360 | ||||||
Notes payable |
482,587 | 176,951 | ||||||
Current portion of capital lease obligations |
3,295 | 4,076 | ||||||
Total current liabilities |
3,837,372 | 4,097,035 | ||||||
Capital lease obligation |
| 174 | ||||||
Commitments |
||||||||
Stockholders equity: |
||||||||
Common stock, $.001 par value; 100,000,000 shares authorized; 4,494,263 shares issued and outstanding at December 31, 2003 and September 30, 2003 |
2,273 | 2,273 | ||||||
Additional paid-in-capital |
2,848,027 | 2,848,027 | ||||||
Accumulated deficit |
(4,928,443 | ) | (5,054,131 | ) | ||||
Total stockholders equity |
(2,078,143 | ) | (2,203,831 | ) | ||||
Total liabilities and stockholders equity |
$ | 1,759,229 | $ | 1,893,378 | ||||
The accompanying notes are an integral part of these financial statements.
3
Statements of Operations
Three Months Ending December 31, |
||||||||
2003 |
2002 |
|||||||
Net revenues |
$ | 1,011,165 | 1,060,371 | |||||
Direct costs |
436,943 | 503,917 | ||||||
Gross profit |
574,222 | 556,454 | ||||||
Marketing and sales expenses |
125,934 | 401,109 | ||||||
General and administrative expenses |
315,756 | 384,937 | ||||||
Operating income (loss) |
132,532 | (229,592 | ) | |||||
Other expense |
||||||||
Interest expense |
(6,844 | ) | (7,208 | ) | ||||
(6,844 | ) | (7,208 | ) | |||||
Net income (loss) |
$ | 125,688 | $ | (236,800 | ) | |||
Per share data: |
||||||||
Basic income (loss) |
$ | 0.03 | $ | (0.05 | ) | |||
Diluted income (loss) |
$ | 0.03 | $ | (0.05 | ) | |||
Basic weighted average shares Outstanding |
4,494,263 | 4,431,101 | ||||||
Diluted weighted average shares Outstanding |
4,508,303 | 4,431,101 | ||||||
The accompanying notes are an integral part of these financial statements.
4
Statements of Cash Flows
Three Months Ended December 31, |
||||||||
2003 |
2002 |
|||||||
Cash flows from operating activities |
||||||||
Net income (loss) |
$ | 125,688 | $ | (236,800 | ) | |||
Adjustments to reconcile net income (loss) to net cash used in operating activities: |
||||||||
Depreciation and amortization |
10,360 | 6,157 | ||||||
Change in operating assets and liabilities: |
||||||||
Accounts receivable |
(148,832 | ) | (263,472 | ) | ||||
Prepaid expenses and other assets |
121,300 | 13,130 | ||||||
Accounts payable |
(97,162 | ) | 85,014 | |||||
Accrued salaries and benefits |
(33,669 | ) | (20,005 | ) | ||||
Deferred revenue and other accrued liabilities |
(433,687 | ) | (342,263 | ) | ||||
Net cash used in operating activities |
(456,002 | ) | (758,239 | ) | ||||
Cash flows from investing activities |
||||||||
Purchase of equipment |
| | ||||||
Net cash used in investing activities |
| | ||||||
Cash flows from financing activities |
||||||||
Borrowings (repayments) of short-term debt |
305,636 | (21,820 | ) | |||||
Sale of stock and other issuances |
| 2,334 | ||||||
Repayments of capital lease obligations |
(955 | ) | (3,099 | ) | ||||
Net cash provided by (used in) financing activities |
304,681 | (22,585 | ) | |||||
Net (decrease) in cash |
(151,321 | ) | (780,824 | ) | ||||
Cash at beginning of period |
249,831 | 1,175,945 | ||||||
Cash at end of period |
$ | 98,510 | $ | 395,121 | ||||
The accompanying notes are an integral part of these financial statements.
5
Notes to Financial Statements
December 31, 2003 and 2002
(Unaudited)
1. Description of the Business
Alliance HealthCard, Inc. (hereinafter referred to as Alliance or the Company) specializes in creating, marketing and distributing value added healthcare savings programs, services, and products. Alliance gives individuals and families access to healthcare providers offering up to 16 major healthcare services at significantly discounted fees for a low annual fee. Alliance markets to predominantly underserved markets where individuals either have limited health benefits, or no insurance. These markets may vary widely from senior populations with Medicare (no prescription benefits), part-time employees, to pockets of the over 40 million uninsured looking for lower cost medical services and access to providers.
2. Summary of Significant Accounting Policies
The accompanying financial statements are un-audited and have been prepared by management of the Company in accordance with the rules and regulations of the Securities and Exchange Commission. The un-audited financial information furnished herein in the opinion of management reflects all adjustments, which are of a normal recurring nature, that are necessary to fairly state the Companys financial position, the results of its operations and its cash flows. For further information refer to the financial statements and footnotes thereto included in the Companys Form 10-KSB for the year ended September 30, 2003. Footnote disclosures, which would substantially duplicate the disclosure contained in those documents, have been omitted.
Net income (loss) per share is computed in accordance with SFAS No. 128 Earnings per Share. Basic and diluted net loss per share are the same for the three months ended December 31, 2002 because the Companys potentially dilutive securities are anti-dilutive in such periods.
6
ITEM 2. | MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS |
General
Alliance HealthCard, Inc. specializes in creating, marketing and distributing value added healthcare savings programs, services, and products. Alliance gives individuals and families access to healthcare providers offering up to 16 major healthcare services at significantly discounted fees for a low annual fee. Alliance markets to predominantly underserved markets where individuals either have limited health benefits, or no insurance. These markets may vary widely from senior populations with Medicare (no prescription benefits), part-time employees, to pockets of the over 40 million uninsured looking for lower cost medical services and access to providers.
Results of Operations
Three Months Ended December 31, 2003, Compared to Three Months Ended December 31, 2002
Net revenues for the Company decreased to $1,011,165 for the three months ended December 31, 2003 from $1,060,371 for the three months ended December 31, 2002. The decrease is attributable to the termination of the Bankers Fidelity Life Insurance Company contract in 2003.
Gross profit increased $17,768 to $574,222 for the three months ended December 31, 2003 from $556,454 for the same prior year period. The increase in gross profit was primarily attributable to a reduction of implementation expense for the State Farm Mutual Automobile Insurance Company. For total contract implementation costs in excess of $5,000, the Company records that expense over the first twelve-month term of the contract. The first twelve-month term of the State Farm contract ended on June 30, 2003.
Marketing and sales expenses decreased to $125,934 for the three months ended December 31, 2003, from $401,109 in the same prior year period. The large decrease is due to a reduction of royalty expense resulting from an amendment to the CVS Pharmacy, Inc. contract in 2003.
General and administrative expenses decreased to $315,756 for the three months ended December 31, 2003 from $384,937 in the same prior year period. The decrease is primarily attributable to a decrease in compensation expense resulting from a reduction in personnel and consultants, as the Company continues to manage its infrastructure to maximize the Companys profits.
Interest expense slightly decreased to $6,844 for the three months ended December 31, 2003 from $7,208 for the same prior year quarter.
The Company reported net income of $125,688 for the three months ended December 31, 2003 compared to a net loss of $236,800 for the same prior year period. The decrease of $362,488 resulted from the reduction in marketing, sales and general administrative expenses as discussed above.
7
Liquidity and Capital Resources
The Companys operations used cash of $456,002 for the three months ended December 31, 2003 as a result of the following: a) net income of $125,688; b) an increase in accounts receivable of 148,832; c) a decrease in other liabilities of $433,687 which was primarily the result of a decrease in deferred revenue of $480,783 related to the State Farm and CVS contracts. Membership fees are generally paid to the Company on a monthly or annual basis. Membership fees paid in advance on an annual basis are recognized monthly over the applicable twelve-month membership term.
The Companys net working capital increased $135,874 to $(2,153,741) for the three months ended December 31, 2003 from $(2,289,615) at September 30, 2003. The increase in working capital was primarily caused by a decrease in accounts payable and accrued compensation for the year ended September 30, 2003.
The Companys financing activities for the three months ended December 31, 2003 provided cash of $304,681 primarily from an increase in the outstanding balance on the Companys line of credit. The Company has $174,800 available on its line of credit at December 31, 2003.
ITEM 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK |
The Company has no material exposure to market risk from derivatives or other financial instruments.
PART II. OTHER INFORMATION
Item 6. | Exhibits and Reports on Form 8-K |
(a) The Company did not file any reports on Form 8-K during the three months ended December 31, 2003.
Exhibits
Exhibit 31.1 Certification Pursuant to Rule 13a-14(a) under the Securities Exchange act of 1934, as amended
Exhibit 31.2 Certification Pursuant to Rule 13a-14(a) under the Securities Exchange act of 1934, as amended.
Exhibit 32.1 Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Exhibit 32.2 Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
8
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Alliance HealthCard, Inc. | ||||||||
February 11, 2004 | By: | /s/ Robert D. Garces | ||||||
Robert D. Garces Chairman and Chief Executive Officer (Principal Executive Officer) |
February 11, 2004 | By: | /s/ Rita McKeown | ||||||
Rita McKeown Chief Financial Officer (Principal Financial and Accounting Officer) |
9